In this phase I/II study, 11 patients with CD19 + lymphoid malignancies (five CLL including two Richter’s syndromes and six DLBCL) received CAR-NK cells with HLA mismatch [34]. The gene discussed is CD19; the disease is diffuse large B-cell lymphoma.